Medicines information
Medicines information services benefit patients
Pharmacy-led medicines information services improve patient care and clinical outcomes, results of a UK-wide study confirm[1].
Researchers analysed enquiries made by 647 pharmacists, doctors and nurses to 62 medicines information services.
Based questionnaires, 81% of respondents sought advice from the service before proceeding with their patient’s treatment. Some 85% of respondents said the advice had helped their patients or improved clinical outcome.
Medicines safety was also improved in 77% of cases and 15% of patients avoided a major risk. In 22% of cases, medicines information pharmacists raised clinical issues not previously considered by the health professionals, the research reveals.
A multidisciplinary panel of healthcare professionals independently assessed the impact of advice for a sample of enquiries.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20065523
Recommended from Pharmaceutical Press
- Previous
- Next
BNF and British National Formulary for Children
Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.
£138.50Buy now
BNF and British National Formulary for Children
Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.
£262.50Buy now
Essentials of Economic Evaluation in Healthcare
An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.
£33.00Buy now
Pharmaceutical Toxicology
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.
£40.00Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.